NCT01859351View on ClinicalTrials.gov

Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Advanced Solid Tumours
Interventions
DRUG

WX-037

DRUG

WX-554

Trial Locations (3)

SM2 5PT

Royal Marsden NHS Foundation Trust, Sutton

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

SE1 9RT

Guy's and St Thomas' Foundation Trust, Guy's Hospital, London

Sponsors
All Listed Sponsors
lead

Heidelberg Pharma AG

INDUSTRY

NCT01859351 - Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours | Biotech Hunter | Biotech Hunter